Literature DB >> 29262301

Drug nanocrystals - Versatile option for formulation of poorly soluble materials.

Leena Peltonen1, Jouni Hirvonen2.   

Abstract

Poor solubility of drug compounds is a great issue in drug industry today and decreasing particle size is one efficient and simple way to overcome this challenge. Drug nanocrystals are solid nanosized drug particles, which are covered by a stabilizer layer. In nanoscale many physical properties, like compound solubility, are different from the solubility of bulk material, and due to this drug nanocrystals can reach supersaturation as compared to thermodynamic solubility. The most important effect of the smaller particle size is that dissolution rate is highly enhanced mainly due to the increased surface area. In this review the most important properties of nanocrystalline drug compounds are presented, with multiple examples of the development and characterization of nanocrystalline drug formulations.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug nanocrystals; Formulation; Poor solubility

Mesh:

Substances:

Year:  2017        PMID: 29262301     DOI: 10.1016/j.ijpharm.2017.12.005

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  14 in total

Review 1.  Bioavailability Enhancement of Poorly Water-Soluble Drugs via Nanocomposites: Formulation⁻Processing Aspects and Challenges.

Authors:  Anagha Bhakay; Mahbubur Rahman; Rajesh N Dave; Ecevit Bilgili
Journal:  Pharmaceutics       Date:  2018-07-08       Impact factor: 6.321

Review 2.  Nanocrystals of Poorly Soluble Drugs: Drug Bioavailability and Physicochemical Stability.

Authors:  Maria Rosa Gigliobianco; Cristina Casadidio; Roberta Censi; Piera Di Martino
Journal:  Pharmaceutics       Date:  2018-08-21       Impact factor: 6.321

Review 3.  Advanced modification of drug nanocrystals by using novel fabrication and downstream approaches for tailor-made drug delivery.

Authors:  Tao Liu; Xinxin Yu; Haipeng Yin; Jan P Möschwitzer
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

Review 4.  Advancement of nanomedicines in chronic inflammatory disorders.

Authors:  Vikas Jogpal; Mohit Sanduja; Rohit Dutt; Vandana Garg
Journal:  Inflammopharmacology       Date:  2022-02-25       Impact factor: 5.093

5.  Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability.

Authors:  Muhammad Ayub Khan; Muhammad Mohsin Ansari; Sadia Tabassam Arif; Abida Raza; Ho-Ik Choi; Chang-Wan Lim; Ha-Yeon Noh; Jin-Su Noh; Salman Akram; Hafiz Awais Nawaz; Muhammad Ammad; Abir Abdullah Alamro; Amani Ahmed Alghamdi; Jin-Ki Kim; Alam Zeb
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

6.  A Systematic Approach to the Development of Cilostazol Nanosuspension by Liquid Antisolvent Precipitation (LASP) and Its Combination with Ultrasound.

Authors:  Emilia Jakubowska; Bartłomiej Milanowski; Janina Lulek
Journal:  Int J Mol Sci       Date:  2021-11-17       Impact factor: 5.923

7.  Biomimetic Synthesis and Evaluation of Interconnected Bimodal Mesostructured MSF@Poly(Ethyleneimine)s for Improved Drug Loading and Oral Adsorption of the Poorly Water-Soluble Drug, Ibuprofen.

Authors:  Wei Xin; Yumei Wang; Xianmou Guo; Kaijun Gou; Jing Li; Sanming Li; Lin Zhao; Heran Li
Journal:  Int J Nanomedicine       Date:  2020-10-05

8.  3D Printing of Drug Nanocrystals for Film Formulations.

Authors:  Giorgia Germini; Leena Peltonen
Journal:  Molecules       Date:  2021-06-28       Impact factor: 4.411

9.  Scalable flibanserin nanocrystal-based novel sublingual platform for female hypoactive sexual desire disorder: engineering, optimization adopting the desirability function approach and in vivo pharmacokinetic study.

Authors:  Marianne J Naguib; Amal I A Makhlouf
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

Review 10.  Design Space and QbD Approach for Production of Drug Nanocrystals by Wet Media Milling Techniques.

Authors:  Leena Peltonen
Journal:  Pharmaceutics       Date:  2018-07-25       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.